u5
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 1
, Chapter 1 - The Nursing Process and Drug Therapy __________________________________ 3
u5 u5 u5 u5 u5 u5 u 5 u5
Chapter 2 - Pharmacologic Principles _____________________________________________ 7
u5 u5 u 5 u5
Chapter 3 - Lifespan Considerations ______________________________________________ 13
u5 u5 u5 u5
Chapter 4 - Cultural Legal and Ethical Considerations ________________________________ 19
u5 u5 u5 u5 u5 u 5 u5
Chapter 5 - Medication Errors Preventing and Responding ____________________________ 25
u5 u5 u5 u5 u5 u 5 u5
Chapter 6 - Patient Education and Drug Therapy ____________________________________ 29
u5 u5 u5 u5 u5 u 5 u5
Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary Supplements __________________ 34
u5 u5 u5 u5 u5 u5 u5 u5 u5
Chapter 8 - Gene Therapy and Pharmacogenomics __________________________________ 38
u5 u5 u5 u5 u 5 u5
Chapter 9 - Photo Atlas of Drug Administration _____________________________________ 42
u5 u5 u5 u5 jc u 5 u5
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM
u5 u5 u5 u5 u5 u5 u5
Chapter 10 - Analgesic Drugs ___________________________________________________ 50
u5 u5 u5 u5
Chapter 11 - General and Local Anesthetics ________________________________________ 57
u5 u5 u5 u5 u 5 u5
Chapter 12 - Central Nervous System Depressants and Muscle Relaxants 61 Chapter 13 -
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
Central Nervous System Stimulants and Related Drugs _____________________________ 66
u 5 u5 u5 u5 u 5 u5
Chapter 14 - Antiepileptic Drugs_________________________________________________ 70
u5 u5 u5 u5
Chapter 15 - Anti-Parkinson Drugs _______________________________________________ 75
u5 u5 u5 u5
Chapter 16 - Psychotherapeutic Drugs ____________________________________________ 80
u5 u5 u 5 u5
Chapter 17 - Substance Use Disorder _____________________________________________ 87
u5 u5 u5 u 5 u5
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM
u5 u5 u5 u5 u5 u5 u5
Chapter 18 - Adrenergic Drugs __________________________________________________ 92
u5 u5 u5 u5
Chapter 19 - Adrenergic-Blocking Drugs __________________________________________ 97
u5 u5 u 5 u5
Chapter 20 - Cholinergic Drugs__________________________________________________ 102
u5 u5 u5 u5
Chapter 21 - Cholinergic-Blocking Drugs _________________________________________ 107
u5 u5 u 5 u5
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS
u5 u5 u5 u5 u5 jc u5 u5
Chapter 22 - Antihypertensive Drugs _____________________________________________ 112
u5 u5 u 5 u5
Chapter 23 - Antianginal Drugs _________________________________________________ 118
u5 u5 u5 u5
Chapter 24 - Heart Failure Drugs_________________________________________________ 124
u5 u5 u5 u 5 u5
Chapter25 - Antidysrhythmic Drugs _____________________________________________ 129
u5 u5 u5 u5
Chapter 26 - Coagulation Modifier Drugs__________________________________________ 134
u5 u5 u5 u 5 u5
Chapter 27 - Antilipemic Drugs _________________________________________________ 140
u5 u5 u5 u5
Chapter 28 - Diuretic Drugs _____________________________________________________ 145
u5 u5 u5 u5
Chapter 29 - Fluids and Electrolytes ______________________________________________ 151
u5 u5 u5 u 5 u5
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS
u5 u5 u5 u5 u5 u5 u5 u5
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 2
, Chapter 30 - Pituitary Drugs ____________________________________________________ 157
u5 u5 u5 u5
Chapter 31 - Thyroid and Antithyroid Drugs _______________________________________ 161
u5 u5 u5 u5 u 5 u5
Chapter 32 - Antidiabetic Drugs _________________________________________________ 166
u5 u5 u5 u5
Chapter 33 - Adrenal Drugs _____________________________________________________ 174
u5 u5 u5 u5
Chapter 34 - Women’s Health Drugs______________________________________________ 178
u5 u5 u5 u 5 u5
Chapter 35 - Men’s Health Drugs ________________________________________________ 185
u5 u5 u5 u 5 u5
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM
u5 u5 u5 u5 u5 u5
Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants __________________ 189
u5 u5 u5 u5 u5 u5 u5
Chapter 37 - Respiratory Drugs __________________________________________________ 194
u5 u5 u5 u5
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS
u5 u5 u5 u5 u5
Chapter 38 - Antibiotics Part 1___________________________________________________ 199
u5 u5 u5 u5 u5
Chapter 39 - Antibiotics Part 2___________________________________________________ 206
u5 u5 u5 u5 u5
Chapter 40 - Antiviral Drugs ____________________________________________________ 211
u5 u5 u5 u5
Chapter 41 - Antitubercular Drugs _______________________________________________ 216
u5 u5 u 5 u5
Chapter 42 - Antifungal Drugs __________________________________________________ 221
u5 u5 u5 u5
Chapter43 - Antimalarial Antiprotozoal and Anthelmintic Drugs _______________________ 226
u5 u5 u5 u5 u5 u 5 u5
Chapter 44 - Anti-inflammatory and Antigout Drugs _________________________________ 231
u5 u5 u5 u5 u 5 u5
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC
AND IMMUNE MODIFIERS
u5 u5
Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell Cycle _________________ 236
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
Chapter46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and Misc. Drugs ___________ 242
u5 u5 u5 u5 u5 jc u5 u5 u5 u5 u 5 u5
Chapter47 - Biologic Response–Modifying and Antirheumatic Drugs ___________________ 247
u5 u5 u5 u5 u5 u 5 u5
Chapter48 - Immunosuppressant Drugs ___________________________________________ 252
u5 u5 u 5 u5
Chapter49 - Immunizing Drugs _________________________________________________ 257
u5 u5 u5 u5
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION
u5 u5 u5 u5 u5 u5 u5 u5
Chapter 50 - Acid-Controlling Drugs _____________________________________________ 262
u5 u5 u5 u5
Chapter 51 - Bowel Disorder Drugs ______________________________________________ 268
u5 u5 u5 u 5 u5
Chapter 52 - Antiemetic and Antinausea Drugs _____________________________________ 275
u5 u5 u5 u5 u 5 u5
Chapter 53 - Vitamins and Minerals ______________________________________________ 280
u5 u5 u5 u 5 u5
Chapter 54 - Anemia Drugs _____________________________________________________ 286
u5 u5 u5 u5
Chapter 55 - Nutritional Supplements_____________________________________________ 292
u5 u5 u 5 u5
PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS
u5 u5 u5 u5 u5 u5
Chapter 56 - Drugs ____________________________________________________________ 296
u5 u5 u5
Chapter 57 - Ophthalmic Drugs _________________________________________________ 302
u5 u5 u5 u5
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 3
, Chapter 58 - Otic Drugs ________________________________________________________ 307
u5 u5 u5 u5
Chapter 01: The Nursing Process and Drug Therapy Lilley:
u5 u5 u5 u5 u5 u5 u5 u5 u5
Pharmacology and the Nursing Process, 11th Edition u5 u5 u5 jc u5 u5
MULTIPLE CHOICE u5
1. The nurse is developing a human needs statement for a patient who has a new diagnosis of he ar
u5 u5 u5 u5 u5 jc u5 u5 u5 u5 jc u5 u5 u5 u5 jc u5 u5
t failure. Identification of human needs statements occur with which of these activities?
u5 u5 jc u5 jc u5 u5 u5 u5 jc u5 u5
a. Collection of patient data u5 u5 u5
b. Administering interventions u5
c. Deciding on patient outcomes jc jc u5
d. Documenting the patient’s behavior u5 u5 u5
ANS:A
Identification of human needs occurs with the collection of patient data. u5 u5 u5 u5 jc u5 u5 u5 u5 u5
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process
u5 u5 u5 jc u5 u5 jc
: Human Needs Statement
u5 u5 jc
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
u5 u5 u5 u5 u5 u5 u5 u5 u5
2. Thepatient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nursewas bu s
jc u5 jc u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
y and gave the medication 2 hours after the scheduled dose was due. What type of probl e
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
m does this represent?
u5 u5 u5
a. “Right time” u5
b. “Right dose” u5
c. “Right route” u5
d. “Right medication” u5
ANS:A
“Right time” is correct because the medication was given more than 30 minutes after the
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 4
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 1
, Chapter 1 - The Nursing Process and Drug Therapy __________________________________ 3
u5 u5 u5 u5 u5 u5 u 5 u5
Chapter 2 - Pharmacologic Principles _____________________________________________ 7
u5 u5 u 5 u5
Chapter 3 - Lifespan Considerations ______________________________________________ 13
u5 u5 u5 u5
Chapter 4 - Cultural Legal and Ethical Considerations ________________________________ 19
u5 u5 u5 u5 u5 u 5 u5
Chapter 5 - Medication Errors Preventing and Responding ____________________________ 25
u5 u5 u5 u5 u5 u 5 u5
Chapter 6 - Patient Education and Drug Therapy ____________________________________ 29
u5 u5 u5 u5 u5 u 5 u5
Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary Supplements __________________ 34
u5 u5 u5 u5 u5 u5 u5 u5 u5
Chapter 8 - Gene Therapy and Pharmacogenomics __________________________________ 38
u5 u5 u5 u5 u 5 u5
Chapter 9 - Photo Atlas of Drug Administration _____________________________________ 42
u5 u5 u5 u5 jc u 5 u5
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM
u5 u5 u5 u5 u5 u5 u5
Chapter 10 - Analgesic Drugs ___________________________________________________ 50
u5 u5 u5 u5
Chapter 11 - General and Local Anesthetics ________________________________________ 57
u5 u5 u5 u5 u 5 u5
Chapter 12 - Central Nervous System Depressants and Muscle Relaxants 61 Chapter 13 -
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
Central Nervous System Stimulants and Related Drugs _____________________________ 66
u 5 u5 u5 u5 u 5 u5
Chapter 14 - Antiepileptic Drugs_________________________________________________ 70
u5 u5 u5 u5
Chapter 15 - Anti-Parkinson Drugs _______________________________________________ 75
u5 u5 u5 u5
Chapter 16 - Psychotherapeutic Drugs ____________________________________________ 80
u5 u5 u 5 u5
Chapter 17 - Substance Use Disorder _____________________________________________ 87
u5 u5 u5 u 5 u5
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM
u5 u5 u5 u5 u5 u5 u5
Chapter 18 - Adrenergic Drugs __________________________________________________ 92
u5 u5 u5 u5
Chapter 19 - Adrenergic-Blocking Drugs __________________________________________ 97
u5 u5 u 5 u5
Chapter 20 - Cholinergic Drugs__________________________________________________ 102
u5 u5 u5 u5
Chapter 21 - Cholinergic-Blocking Drugs _________________________________________ 107
u5 u5 u 5 u5
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS
u5 u5 u5 u5 u5 jc u5 u5
Chapter 22 - Antihypertensive Drugs _____________________________________________ 112
u5 u5 u 5 u5
Chapter 23 - Antianginal Drugs _________________________________________________ 118
u5 u5 u5 u5
Chapter 24 - Heart Failure Drugs_________________________________________________ 124
u5 u5 u5 u 5 u5
Chapter25 - Antidysrhythmic Drugs _____________________________________________ 129
u5 u5 u5 u5
Chapter 26 - Coagulation Modifier Drugs__________________________________________ 134
u5 u5 u5 u 5 u5
Chapter 27 - Antilipemic Drugs _________________________________________________ 140
u5 u5 u5 u5
Chapter 28 - Diuretic Drugs _____________________________________________________ 145
u5 u5 u5 u5
Chapter 29 - Fluids and Electrolytes ______________________________________________ 151
u5 u5 u5 u 5 u5
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS
u5 u5 u5 u5 u5 u5 u5 u5
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 2
, Chapter 30 - Pituitary Drugs ____________________________________________________ 157
u5 u5 u5 u5
Chapter 31 - Thyroid and Antithyroid Drugs _______________________________________ 161
u5 u5 u5 u5 u 5 u5
Chapter 32 - Antidiabetic Drugs _________________________________________________ 166
u5 u5 u5 u5
Chapter 33 - Adrenal Drugs _____________________________________________________ 174
u5 u5 u5 u5
Chapter 34 - Women’s Health Drugs______________________________________________ 178
u5 u5 u5 u 5 u5
Chapter 35 - Men’s Health Drugs ________________________________________________ 185
u5 u5 u5 u 5 u5
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM
u5 u5 u5 u5 u5 u5
Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants __________________ 189
u5 u5 u5 u5 u5 u5 u5
Chapter 37 - Respiratory Drugs __________________________________________________ 194
u5 u5 u5 u5
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS
u5 u5 u5 u5 u5
Chapter 38 - Antibiotics Part 1___________________________________________________ 199
u5 u5 u5 u5 u5
Chapter 39 - Antibiotics Part 2___________________________________________________ 206
u5 u5 u5 u5 u5
Chapter 40 - Antiviral Drugs ____________________________________________________ 211
u5 u5 u5 u5
Chapter 41 - Antitubercular Drugs _______________________________________________ 216
u5 u5 u 5 u5
Chapter 42 - Antifungal Drugs __________________________________________________ 221
u5 u5 u5 u5
Chapter43 - Antimalarial Antiprotozoal and Anthelmintic Drugs _______________________ 226
u5 u5 u5 u5 u5 u 5 u5
Chapter 44 - Anti-inflammatory and Antigout Drugs _________________________________ 231
u5 u5 u5 u5 u 5 u5
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC
AND IMMUNE MODIFIERS
u5 u5
Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell Cycle _________________ 236
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
Chapter46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and Misc. Drugs ___________ 242
u5 u5 u5 u5 u5 jc u5 u5 u5 u5 u 5 u5
Chapter47 - Biologic Response–Modifying and Antirheumatic Drugs ___________________ 247
u5 u5 u5 u5 u5 u 5 u5
Chapter48 - Immunosuppressant Drugs ___________________________________________ 252
u5 u5 u 5 u5
Chapter49 - Immunizing Drugs _________________________________________________ 257
u5 u5 u5 u5
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION
u5 u5 u5 u5 u5 u5 u5 u5
Chapter 50 - Acid-Controlling Drugs _____________________________________________ 262
u5 u5 u5 u5
Chapter 51 - Bowel Disorder Drugs ______________________________________________ 268
u5 u5 u5 u 5 u5
Chapter 52 - Antiemetic and Antinausea Drugs _____________________________________ 275
u5 u5 u5 u5 u 5 u5
Chapter 53 - Vitamins and Minerals ______________________________________________ 280
u5 u5 u5 u 5 u5
Chapter 54 - Anemia Drugs _____________________________________________________ 286
u5 u5 u5 u5
Chapter 55 - Nutritional Supplements_____________________________________________ 292
u5 u5 u 5 u5
PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS
u5 u5 u5 u5 u5 u5
Chapter 56 - Drugs ____________________________________________________________ 296
u5 u5 u5
Chapter 57 - Ophthalmic Drugs _________________________________________________ 302
u5 u5 u5 u5
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 3
, Chapter 58 - Otic Drugs ________________________________________________________ 307
u5 u5 u5 u5
Chapter 01: The Nursing Process and Drug Therapy Lilley:
u5 u5 u5 u5 u5 u5 u5 u5 u5
Pharmacology and the Nursing Process, 11th Edition u5 u5 u5 jc u5 u5
MULTIPLE CHOICE u5
1. The nurse is developing a human needs statement for a patient who has a new diagnosis of he ar
u5 u5 u5 u5 u5 jc u5 u5 u5 u5 jc u5 u5 u5 u5 jc u5 u5
t failure. Identification of human needs statements occur with which of these activities?
u5 u5 jc u5 jc u5 u5 u5 u5 jc u5 u5
a. Collection of patient data u5 u5 u5
b. Administering interventions u5
c. Deciding on patient outcomes jc jc u5
d. Documenting the patient’s behavior u5 u5 u5
ANS:A
Identification of human needs occurs with the collection of patient data. u5 u5 u5 u5 jc u5 u5 u5 u5 u5
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process
u5 u5 u5 jc u5 u5 jc
: Human Needs Statement
u5 u5 jc
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
u5 u5 u5 u5 u5 u5 u5 u5 u5
2. Thepatient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nursewas bu s
jc u5 jc u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
y and gave the medication 2 hours after the scheduled dose was due. What type of probl e
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
m does this represent?
u5 u5 u5
a. “Right time” u5
b. “Right dose” u5
c. “Right route” u5
d. “Right medication” u5
ANS:A
“Right time” is correct because the medication was given more than 30 minutes after the
u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5 u5
Chapter 1 - The Nursing Process and Drug Therapy
u5 u5 u5 u5 u5 u5 u5 u5 4
